PRCT PROCEPT BioRobotics Corp

CIK 0001588978 45 ready 8-Ks latest April 29, 2026, 7:59 PM ET RSS · JSON

Activity: QUIET 0 filings / 30d vs 1 baseline

Ready 8-Ks 45

Latest filing June 10, 2026, 4:33 PM ET

Top materiality 0.85

Event mix earnings ×21 · other_material ×12 · leadership ×5

Sentiment 20 pos · 0 neg · 25 neu

Latest earnings reported 2026-Q1

Executive change recent →

Recent 8-K filings for PRCT

Highest-materiality recent filing

PROCEPT BioRobotics Q4 revenue up 57% to $68.2M; guides FY2025 revenue ~$320M (+42%)

February 25, 2025, 6:59 PM ET earnings materiality 0.85 positive item 2.02 item 9.01

Q4 rev $68.2M (+57% YoY); US system rev $27.6M (+67%); handpiece rev $29.3M (+36%).
FY2024 rev $224.5M (+65%); net loss narrowed to $91.4M from $105.9M; adj EBITDA loss $61.1M vs $86.5M.

Read filing →

April 29, 2026, 7:59 PM ET earnings materiality 0.60 neutral item 2.02 item 9.01 ◈ Earnings Releases

PROCEPT BioRobotics Reports Q1 2026 Revenue of $83.1M, Up 20% YoY; Net Loss Widens to $31.6M

Total revenue $83.1M, +20% YoY; U.S. procedures 12,200, +30% YoY.
February 25, 2026, 6:59 PM ET earnings materiality 0.75 neutral item 2.02 item 9.01

PROCEPT BioRobotics Q4 rev $76.4M (+12% YoY), net loss $29.8M; FY26 guidance $390-410M

Q4 total revenue $76.4M (+12% YoY); U.S. procedures ~12,200 (+69% YoY).
November 4, 2025, 6:59 PM ET earnings materiality 0.80 positive item 2.02 item 9.01

PROCEPT Q3 revenue $83.3M (+43% YoY); issues FY2026 guidance $410M-$430M

Q3 total revenue $83.3M, up 43% YoY; U.S. handpiece/consumables $44.4M (+50% YoY).
August 6, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

PROCEPT Q2 revenue $79.2M (+48% YoY); raises FY25 guidance; appoints new CEO

Q2 total revenue $79.2M, up 48% YoY; U.S. handpiece/consumables $43.1M (+58%).
July 25, 2025, 7:59 PM ET leadership materiality 0.75 positive item 2.02 item 5.02 item 7.01 item 9.01

PROCEPT BioRobotics appoints Larry Wood as CEO, pre-announces Q2 revenue of $79.2M (+48% YoY)

Larry L. Wood becomes President and CEO effective Sept 2, 2025; succeeds Reza Zadno who retires.
April 24, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

PROCEPT BioRobotics Q1 revenue up 55% to $69.2M; raises FY2025 guidance to $323M

Total revenue $69.2M, +55% YoY; U.S. revenue $60.3M (+50%); international $8.9M (+104%).
February 25, 2025, 6:59 PM ET earnings materiality 0.85 positive item 2.02 item 9.01

PROCEPT BioRobotics Q4 revenue up 57% to $68.2M; guides FY2025 revenue ~$320M (+42%)

Q4 rev $68.2M (+57% YoY); US system rev $27.6M (+67%); handpiece rev $29.3M (+36%).
October 31, 2024, 7:59 PM ET other material materiality 0.60 neutral item 8.01 item 9.01

PROCEPT BioRobotics issues ~1.92M shares at $91/share, nets ~$163.8M in public offering

Company sold 1,923,076 shares at $91 per share; net proceeds to company were ~$163.8M after discounts and expenses.
October 28, 2024, 7:59 PM ET earnings materiality 0.85 positive item 2.02 item 9.01

PROCEPT BioRobotics Q3 revenue $58.4M (+66% YoY); raises 2024 revenue and EBITDA guidance

Q3 revenue $58.4M, up 66% YoY; U.S. handpiece+consumables $29.6M (+74%).
August 21, 2024, 7:59 PM ET regulatory materiality 0.65 positive item 8.01

PROCEPT BioRobotics receives FDA 510(k) clearance for HYDROS Robotic System

HYDROS features FirstAssist AI for AI-powered treatment planning using real-world procedure data.
August 1, 2024, 7:59 PM ET earnings materiality 0.85 positive item 2.02 item 9.01

PROCEPT BioRobotics Q2 revenue $53.4M (+61% YoY); raises FY2024 revenue and EBITDA guidance

Total revenue $53.4M (+61% YoY); U.S. handpiece & consumables $27.3M (+101% YoY).
November 1, 2023, 7:59 PM ET earnings materiality 0.80 positive item 2.02 item 9.01 ◈ Earnings Releases ×2

PROCEPT BioRobotics Q3 revenue $35.1M (+72% YoY); raises FY2023 guidance to $133.5M

Revenue $35.1M, up 72% YoY; U.S. handpiece/consumables $17.0M, up 113%.
August 4, 2023, 7:59 PM ET other material materiality 0.75 neutral item 8.01 item 9.01

PROCEPT BioRobotics closes public offering of 5.1M shares, netting $161.3M

Underwriting agreement with BofA Securities, Piper Sandler, Cowen for 4.42M shares at $33.92/share public price.
July 27, 2023, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01 ◈ Earnings Releases ×2

PROCEPT BioRobotics Q2 revenue $33.1M (+98% YoY); raises FY2023 guidance to $131M

Record 40 U.S. AquaBeam systems sold in Q2; U.S. system revenue $14.8M (+74% YoY).
April 27, 2023, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01 ◈ Earnings Releases ×2

PROCEPT BioRobotics Q1 revenue up 72% to $24.4M; raises FY2023 revenue guidance to $128M

Total revenue $24.4M (+72% YoY); U.S. handpiece/consumables $11.8M (+165% YoY).
February 28, 2023, 6:59 PM ET earnings materiality 0.75 neutral item 2.02 item 9.01

PROCEPT BioRobotics Q4 revenue up 135% YoY to $23.8M; guides 2023 revenue ~$125M

Q4 2022 revenue $23.8M (+135% YoY); full year revenue $75.0M (+118% YoY).
January 9, 2023, 6:59 PM ET earnings materiality 0.65 positive item 2.02 item 9.01 ◈ Earnings Releases

PROCEPT BioRobotics pre-announces Q4 rev ~$23.6-23.8M, FY2022 rev ~$74.8-75.0M (+117% YoY)

Q4 2022 revenue expected $23.6M-$23.8M, up from $10.1M in Q4 2021.
November 3, 2022, 7:59 PM ET earnings materiality 0.85 positive item 2.02 item 9.01 ◈ Earnings Releases

PROCEPT BioRobotics Q3 revenue $20.3M (+135% YoY), raises 2022 guidance to ~$72.5M

Total revenue $20.3M, +135% YoY; US system rev $9.8M (+95%), handpiece $8.0M (+267%).
October 11, 2022, 7:59 PM ET debt materiality 0.60 positive item 1.01 item 1.02 item 2.03 item 9.01

PROCEPT BioRobotics closes $52M term loan with CIBC, repays $50M Oxford facility

Entered $52M senior secured term loan with CIBC; fully drawn on Oct 6, 2022.
August 4, 2022, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

PROCEPT BioRobotics Q2 revenue up 97% to $16.7M; raises FY22 revenue guidance to $66-68M

Q2 2022 total revenue $16.7M, +97% YoY; U.S. system revenue $8.5M (+79%), handpiece and consumables $5.7M (+246%).
May 5, 2022, 7:59 PM ET earnings materiality 0.80 positive item 2.02 item 9.01

PROCEPT BioRobotics Q1 revenue $14.2M (+97% YoY); raises FY2022 revenue guidance to $58-62M

Q1 total revenue $14.2M, +97% YoY; U.S. system revenue $7.8M (+70%), handpiece & consumables $4.4M (+174%).
March 8, 2022, 6:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

PROCEPT BioRobotics Q4 revenue $10.1M (+216% YoY); guides FY2022 revenue $54-58M

Revenue $10.1M in Q4 2021, up from $3.2M YoY; full year $34.5M vs $7.7M.
January 11, 2022, 6:59 PM ET earnings materiality 0.70 positive item 2.02 item 9.01

PROCEPT BioRobotics announces preliminary Q4 revenue of $9.8-10.1M, FY 2021 revenue $34.1-34.4M

Q4 2021 revenue expected $9.8M-$10.1M, up from $3.2M in Q4 2020.
January 4, 2022, 6:59 PM ET other material materiality 0.60 neutral item 1.01 item 5.02 item 9.01 ◈ executive_change

PROCEPT BioRobotics signs 10-year lease for 158,221 sq ft San Jose facility; appoints Mary Garrett to board

Lease for 158,221 rentable sq ft in San Jose, CA; term 122 months starting on or before Dec 31, 2022.
November 4, 2021, 7:59 PM ET earnings materiality 0.70 positive item 2.02 item 9.01

PROCEPT Q3 revenue $8.7M up 314% YoY; raises FY 2021 guide to $33.0-$33.3M

Total revenue of $8.7M vs. $2.1M in Q3 2020; U.S. system revenue $5.0M vs. $0.6M.